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BACKGROUND: Provoked vestibulodynia manifests as allodynia of the specific neurofilament epositive intraepithelial fibers were found in 17 of
vulvar vestibular mucosa. The exact mechanisms that result in altered pain
sensation are unknown. Recently, we demonstrated the presence of
secondary lymphoid tissue, which is the vestibule-associated lymphoid
tissue in the vestibular mucosa, and showed that this tissue becomes
activated in provoked vestibulodynia.
OBJECTIVE: The purpose of this study was to examine whether
expression of intraepithelial nerve fibers and nerve growth factor are
related to immune activation in provoked vestibulodynia.
STUDY DESIGN: Vestibular mucosal specimens were obtained from
27 patients with severe provoked vestibulodynia that was treated by
vestibulectomy and from 15 control subjects. We used antibodies against
the protein gene product 9.5, the neuron specific neurofilament, and nerve
growth factor for immunohistochemistry to detect intraepithelial nerve fi-
bers and nerve growth factor expressing immune cells in the vestibular
mucosa. For intraepithelial nerve fibers, we determined their linear density
(fiber counts per millimeter of the outer epithelial surface, protein gene
product 9.5) or presence (neuron specific neurofilament). Nerve growth
factor was analyzed by counting the staining-positive immune cells. An-
tibodies against CD20 (B lymphocytes) and CD3 (T lymphocytes) were
used to identify and locate mucosal areas with increased density of
lymphocytes and the presence of germinal centers (ie, signs of immune
activation). B-cell activation index was used to describe the overall in-
tensity of B-cell infiltration.
RESULTS: We found more protein gene product 9.5epositive intra-
epithelial fibers in vestibulodynia than in the control samples (6.3/mm
[range, 0.0e15.8] vs 2.0/mm [range, 0.0e12.0]; P¼.006). NeuronCite this article as: Tommola P, Unkila-Kallio L, Paetau
A, et al. Immune activation enhances epithelial nerve
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Protein gene product 9.5epositive intraepithelial fibers were more
common in samples with more pronounced immune activation. The
density of these fibers was higher in samples with than without germinal
centers (6.1/mm [range, 4.3e15.8] vs 3.0/mm [range, 0.0e13.4];
P¼.020). A positive correlation between the fiber density and B-cell
activation index score of the sample was found (Spearman’s Rho, 0.400;
P¼.004; R2¼0.128). No significant difference, however, was found in
the density or presence of nerve fibers between samples with high and
low T-cell densities. We identified areas of minor and major vestibular
glands in 16 of the patient samples and in 1 control sample. Protein gene
product 9.5epositive nerve fibers were found more often in glandular
epithelium surrounded by B-cell infiltration than in glands without B cells
(P¼.013). Also, the presence of neuron specific neurofilamentepositive
fibers in glandular epithelium was associated with B-cell infiltrates
(P¼.053). Nerve growth factorepositive immune cells were more
common in mucosal areas with than without B-cell infiltration and
intraepithelial nerve fibers.
CONCLUSION: Excessive epithelial nerve growth in provoked vesti-
bulodynia is associated with increased B-cell infiltration and the presence
of germinal centers. This supports the fundamental role of immune acti-
vation in provoked vestibulodynia.
Key words: germinal center, immune activation, immunohistochem-
istry, inflammation, nerve fibers, NGF, NF2F11, PGP9.5, vestibulodynia,
vulvar pain, vulvar vestibulitis, vulvodyniarovoked vestibulodynia (PVD),P which also is referred to as localized
provoked vulvodynia, manifests as allo-
dynia (severe pain by touch) of the
vulvar vestibular mucosa in the absence
of any other disease or identiﬁable
cause.1
Histopathologic investigation of PVD
typically reveals increased lymphocytic
inﬁltrates in the vestibular mucosa.2,3Recently, we demonstrated the presence
of secondary lymphoid tissue, which is
the vestibule-associated lymphoid tissue
(VALT) in the vestibular mucosa, and
showed that VALT becomes activated in
PVD. We showed higher numbers of B
cells in PVD than in control samples but
found no difference in the density of T
cells between the groups.4 An exagger-
ated immunoinﬂammatory response
and dysregulation of inﬂammation seem
to be present in PVD.5-7 The close rela-
tion between immune and neuronal
systems can activate neuroinﬂammatory
processes and lead to sensitization of
nerve ﬁbers. Immune cells produce
nerve growth factor (NGF), which may
induce nerve sprouting and enhanced
signaling of the nociceptive nerveendings.8 Thus, it is important to study
the interrelation between immune acti-
vation and nerves in PVD. Previous
studies have shown increased density of
nerves in the vestibular mucosa in PVD
and increased expression of transient
receptor potential V1 (TRPV1) channels
in these nerves,9-12 but no speciﬁc data
on the density of intraepithelial nerve
ﬁbers (IENF) or expression of NGF exist.
We wanted to ﬁnd out whether the
density and localization of IENFs and the
expression of NGF are related to im-
mune activation in the vestibular
mucosal tissue in PVD. In addition to the
standard neural marker, the protein gene
product 9.5 (PGP9.5), we used a speciﬁc
marker for neuroﬁlaments.13 To deﬁne
the sites of immune activation, we used 2
ajog.org GYNECOLOGY Original Researchstandard markers, CD20 (B cells) and
CD3 (T cells). We explored the differ-
ences in the expression of IENFs and
NGF between PVD and control samples
and in relation to different B-cell and
T-cell densities.
Material and Methods
Study subjects
The study material consisted of 27
archival vestibulectomy specimens from
posterior vestibulectomy operations.
The patients were identiﬁed in the Hel-
sinki University Hospital patient registry
by matching the diagnosis (vulvar
vestibulitis, vestibulodynia, and vulvo-
dynia) and the surgical procedure (pos-
terior vestibulectomy). Details of patient
recruitment and data collection have
been described previously.4,14 A good
quality parafﬁn block of the tissue
specimen was required. All the included
patients had a long disease history
(4.0 years; range, 2e18 years) of PVD.
The diagnoses for 8 patients were clas-
siﬁed as primary (symptoms already at
the ﬁrst vaginal entry); the diagnoses for
15 patients were classiﬁed as secondary
(symptoms appearing later after an in-
terval of painless intercourses), and the
classiﬁcation for 4 patients was un-
known. All patients had been refractory
to conservative treatments. The time
from the last attempted medical man-
agement was >6 months. As control
subjects, we recruited 15 healthy volun-
teers with no vulvar complaints who
underwent benign gynecologic surgery.
All participants were premenopausal.
Themedian age of the patients with PVD
was 27 years (range, 18e48 years); the
median age of the control subjects was
30 years (range, 24e44 years; P¼.017). A
4-mm punch biopsy specimen from the
posterior vestibule at 5 o’clock position
was obtained from the control subjects.
Both patients and control subjects had
provided informed consent. The local
Ethical Committee approved the study.
Tissues
All vestibular tissues were embedded
routinely in parafﬁn after a maximum of
24 hours ﬁxation in 10% buffered
formalin. Five-micrometer sections were
ﬁrst stained with hematoxylin-eosin toexclude dermatologic diseases and to
conﬁrm the quality of the samples.
Immunohistochemistry for nerve ﬁbers
(10-mm sections) and B and T lympho-
cytes (5-mm sections) was performed at
the Helsinki and Uusimaa Hospital
District Laboratory Services tissue
laboratory. Routine staining procedures
according to the manufactures’ in-
structions were followed (Table). Im-
munostaining for NGF (5-mm sections)
was performed at the Department of
Clinical Chemistry, University of Hel-
sinki (manual staining procedure15;
Table).
Tissue analyses
Immunohistochemical scoring was per-
formed under light microscopy (Nikon
Eclipse E800; Nikon Instruments Inc,
Melville, NY) at 200 magniﬁcation.
The scoring of each section was based on
a consensus of 2 investigators (P.T., A.P.,
or S.M.) who were blinded to clinical
data of the patients. The number of
PGP9.5-positive IENFs was counted to
calculate the linear density of IENFs
(number of nerve ﬁbers /millimeters of
epithelial outer surface). For identiﬁca-
tion of individual ﬁbers, we used the
criteria that had been validated for the
diagnostics of small ﬁber neuropathies.16
Brieﬂy, the ﬁbers were considered to be
separate if there were clearly 2 individual
parallel ﬁbers and if the distance between
2 different perpendicular sections of a
stained axon exceeded 5 times the
diameter of an axon. Only ﬁbers clearly
penetrating into the epithelium through
the basal membrane were counted as
IENFs. For neuron speciﬁc neuroﬁla-
ment (NF2F11)epositive IENFs only
the presence or absence was docu-
mented. The overall density of neural
fasciculi in the neural plexus region in
the subepithelial stroma up to the depth
of 1.25 mm (diameter of the 20
high-power ﬁeld) was scored semi-
quantitatively for both neural markers. A
single number score from 1e3 (1¼low
density, 2¼moderate density, 3¼high
density) was given.
Evaluation of the vestibular glands
was also limited to the depth of 1.25mm.
The glands were identiﬁed on the basis
of typical morphologic condition. AllDECEMBER 2016 Americomparisons were made between PVD
samples and control samples. In PVD
samples, densities of epithelial nerve ﬁ-
bers were also compared between areas
with or without increased B-cell inﬁl-
tration. The representative areas of B-cell
inﬁltration in each sample were located
with the use of CD20 staining. To reﬂect
the overall level of B-cell inﬁltration of
each sample, we used the B-cell activa-
tion index (BAI). BAI is the calculated
sum (0e12) of 3 different parameters
that were analyzed from each sample:
(1) overall density of B cells in the
epithelium (score, 0e4), (2) overall
density of B cells in the stroma (score,
0e4), and (3) absence (score, 0) or
presence (score, 4) of germinal centers.4
T-cell density was divided in the CD3-
stained samples into 2 categories: “low
density” (<50 cells/20 high-power
ﬁeld) and “high density” (>50 cells/20
high-power ﬁeld). Germinal centers were
visualized by CD20 and CD3 stainings.
For NGF quantiﬁcation, 4 types of
areas from the PVD samples were iden-
tiﬁed: (1) areas with increased B-cell
inﬁltration without IENFs, (2) areas
without increased B-cell inﬁltration with
IENFs present, (3) areas with both
increased B-cell inﬁltration and IENFs,
and (4) areas lacking both B-cell inﬁl-
tration and IENFs. The number of NGF-
positive immune cells per visual ﬁeld
(20 high-power ﬁeld) in 3 of each type
of areas in each sample was counted, and
the mean number of positive cells was
calculated. In the control samples, NGF-
positive cells were evaluated only in the
areas with IENFs present because no
areas with increased B-cell inﬁltration
were found.
The data were analyzed by Statistical
Package for Social Sciences software
(version 22; IBM Corporation, Armonk,
NY). We report medians with minimum
and maximum and interquartile range
(IQR, 25e75%) when appropriate for
continuous data. For comparisons, we
used the Mann-Whitney U-test and
Wilcoxon signed ranks test for contin-
uous data and c2 analysis or Fisher’s
exact test for categoric data. For corre-
lations, the Spearman’s correlation test
was used. A 2-tailed probability value of
<.05 was considered signiﬁcant.can Journal of Obstetrics& Gynecology 768.e2
TABLE
Immunohistochemistry procedures
Antibody
Clone; catalog
number;
manufacturer
Pretreatment buffer(pH);
catalog number;
manufacturer
Dilution;
incubation
time/C
Detection system;
catalog number;
manufacturer
Staining
instrument
Protein gene
product 9.5
(PGP9.5)
Polyclonal No pretreatment 1:1000 EnVision Detection
SystemsPeroxidase/DAB
LabVision
RA95101 30 Min/room
temperature
K5007
Ultra Clone Ltd,
Wellow, Isle of Wight, England
Agilent Technologies
Inc, Santa Clara, CA
Neuron specific
neurofilament
(NF2F11)
2F11 Tris-EDTA (pH 9,0) 1:200 EnVision Detection
SystemsPeroxidase/DAB
LabVision
M0762 S2367 30 Min/room
temperature
K5007
Agilent
Technologies Inc
Agilent
Technologies Inc
Agilent
Technologies Inc
CD20 L26 CC1 (pH 8,0) Ready to use UltraView Universal
DAB Detection Kit
Ventana XT
760-2531 24 Min/room
temperature
760-500
Roche Diagnostics
Ltd, Rotkreuz, Switzerland
Roche Diagnostics Ltd Roche Diagnostics Ltd
CD3 2GV6 CC1 (pH 8,0) Ready to use UltraView Universal
DAB Detection Kit
Ventana XT
790-4341 950-124 32 Min/room
temperature
760-500
Roche Diagnostics Ltd Roche Diagnostics Ltd Roche Diagnostics Ltd
Nerve growth
factor (NGF)
Polyclonal EnVision FLEX Target
Retrieval Solution
(pH 6,1)
0.5 mg/mL MACH 4 Universal
AP Polymer Kit, BioCare
Medical, Concord, CA
Manual
sc-548 K8005 Overnight/4C M4U536
Santa Cruz
Biotechnology
Inc, Santa Cruz, CA
Agilent
Technologies Inc
Biocare Medical Inc,
Concord, CA
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Intraepithelial nerve fibers
Because PVDmay be related to increased
pain sensitivity, we looked at individual
nerve ﬁbers in the vestibular epithelium.
Both in PVD samples and control
samples, PGP9.5-positive IENFs were
expressed typically in clusters. Thus,
such areas were studied for PGP9.5-
positive IENFs. PGP9.5-positive IENFs
were found in 24 of the 27 PVD samples
(88.9%) and in 8 of the 15 control768.e3 American Journal of Obstetrics& Gynecolsamples (56.2%). The density of
PGP9.5-positive IENFs was signiﬁcantly
higher in PVD (6.3/mm [range,
0.0e15.8]; IQR, 4.4e9.2) than in con-
trol samples (2.0/mm [range, 0.0e12.0];
IQR, 0.0e4.3; P¼.006; Figure 1, A and
B). No signiﬁcant difference was found
in the density of IENFs between 8 pri-
mary PVD cases (7.5/mm [range,
3.3e15.8]; IQR, 5.3e8.3) and 15 sec-
ondary PVD cases (5.0/mm [range,
0.0e12.4]; IQR, 2.5e9.2; P¼.332).ogy DECEMBER 2016NF2F11-positive IENFs typically
occurred as solitary ﬁbers or in clusters
of 3e8 ﬁbers (Figure 1, C) and were
found in 17 of the 27 PVD cases (63%)
and in none of the control cases
(P<.001). NF2F11-positive IENFs were
as common in primary and secondary
PVD (P¼.627).
IENFs in relation to B-cell infiltrates
Our previous study showed increased
density of B lymphocytes in the vestibular
FIGURE 1
Intraepithelial nerve fibers in the vulvar vestibular mucosa
Intraepithelial nerve fibers (white arrows) A, in provoked vestibulodynia in a mucosal area without
B-lymphocyte infiltration, B, in a control (stained by protein gene product 9.5), C, in provoked
vestibulodynia (stained by neuron specific neurofilament), and D, in provoked vestibulodynia in a
mucosal area with B-lymphocyte infiltration (protein gene product 9.5). E and F show the protein
gene product 9.5estained intraepithelial nerve fibers from panel A in a larger magnification. His-
tologic sections were counterstained with hematoxylin and photomicrographed with a20 objective
(Nikon Eclipse E800; Nikon Instruments Inc., Melville, NY).
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density of PGP9.5-positive IENFs was
greater in the areas with increased B-cell
inﬁltration (5.3/mm; range, 0.0e23.3;
IQR, 3.0e9.4) than in the areas with no B
cells (4.0/mm [range, 0.0e11.3]; IQR,
1.0e8.0; P¼.057; Figure 1, D). In control
samples, no areas with increased B-cell
inﬁltration were found.
IENFs in relation to signs of immune
activation
Germinal centers indicate immune
activation and are the key component ofthe local lymphoid tissue, which we have
termed as VALT.4 Inﬁltrating lympho-
cytes were primarily B cells that were
stained by the CD20 marker. T cells were
distributed more evenly across the sam-
ples and did not form clusters. The
density of PGP9.5-positive IENFs was
signiﬁcantly higher in samples with
germinal centers (6.1/mm [range,
4.3e15.8]; IQR, 5.0e9.4) than in sam-
ples without germinal centers (3.0/mm
[range, 0.0e13.4]; IQR, 0.0e8.4;
P¼.020). A positive correlation between
the density of PGP9.5-positive IENFsDECEMBER 2016 Ameriand the BAI score was found (Spear-
man’s Rho, 0.400; P¼.004; R2¼0.128).
NF2F11-positive IENFs were not asso-
ciated with the presence or absence of
germinal centers. However, the BAI
scores of the samples with NF2F11-
positive IENFs were higher (5.0 [range,
1.0e9.0]; IQR, 4.0e6.0) than the BAI
scores of the samples without ﬁbers (2.0
[range, 1.0e9.0]; IQR, 1.0e3.0;
P¼.005). No differences were found in
the densities of PGP9.5-positive ﬁbers
between the low-density and
high-density T-cell groups (6.8/mm
[range, 0.0e15.8] and 4.6/mm [range,
0.0e12.4], respectively; P¼.112) or in
the presence of NF2F11-positive ﬁbers
(P¼.080).
Glandular epithelium and nerve
fibers in relation to B lymphocytes
Vestibular glands typically occur in the
subepithelial layer of the vulvar vestib-
ular mucosa.17 In the PGP9.5-stained
PVD samples, 14 regions with glan-
dular epithelium were identiﬁed. Of
these, 9 were in areas with increased
lymphocytic inﬁltration that showed a
glandular epithelial nerve ﬁber density
of 25.0/mm (range, 3.1e48.0; IQR,
11.3e32.0; Figure 2, A). Five regions
were in areas without increased numbers
of lymphocytes. Here the glands showed
signiﬁcantly lower epithelial nerve ﬁber
density of 2.0/mm (range, 0.0e17.0;
IQR, 0.0e16.5; P¼.013). In the
control samples, only 1 area of glandular
epithelium was identiﬁed with an
epithelial nerve ﬁber density of 2.0/mm,
which was located in an area with no
lymphocytic inﬁltration. In the NF2F11-
stained PVD samples, 16 glandular re-
gions were identiﬁed, 12 in areas with
lymphocytes and 4 in areas without.
Again, epithelial nerve ﬁbers were pre-
sent more commonly in glands that were
surrounded by lymphocytic inﬁltrates
(11/12) than in glands not surrounded
by lymphocytic inﬁltrates (2/4; P¼.053,
Fisher’s exact test).
Neural fasciculi in the subepithelial
stroma in relation to signs of
immune activation
The densities of the neural fasciculi in
the subepithelial stroma by PGP9.5 orcan Journal of Obstetrics& Gynecology 768.e4
FIGURE 2
Nerve fibers in the vestibular glandular epithelium
Glandular epithelial nerve fibers in provoked vestibulodynia in vestibular mucosal areas with
B-lymphocyte infiltration A and B, immunostaining for protein gene product 9.5, C and D, immu-
nostaining for neuron specific neurofilament. Histologic sections were counterstained with hema-
toxylin and photomicrographed with a 20 objective.
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PVD and control samples (P¼.110 and
.498, respectively) or between primary
and secondary PVD (P¼.289 and .657,
respectively). No association between
neural tissue density and signs of im-
mune activation was found (data not
shown).
NGF-positive immune cells in
relation to lymphocyte infiltrates
and IENFs
NGF is essential in the development of
peripheral nervous system by promoting
growth and survival of neural cells.18 In
mature tissue, it has important roles
both in acute nociception and chronic
pain.19 In the PGP9.5-stained PVD
samples, the number of NGF-positive
immune cells was higher in the areas
with B-cell inﬁltrates and IENFs (20.0;
range, 1.0e102.0) than in the areas
lacking both B-cell inﬁltrates and IENFs
(4.0 [range, 0.0e24.0]; P<.001). Because768.e5 American Journal of Obstetrics& Gynecolof wide variation, there was no signiﬁ-
cant difference between primary and
secondary PVD in the density of NGF-
positive cells (40.0 [range, 1.0e47.0]
and 20.0 [range, 3.0e102.0], respec-
tively; P¼.256). Similarly, densities of
these cells in areas with IENFs did not
differ between PVD and control samples
(20.0 [range, 1.0e102.0] vs 17.5 [range,
0.0e 68.0], respectively; P¼.906;
Figure 3). The numbers of NGF-positive
immune cells did not differ in relation to
T-cell density either (25.0 [range,
1.0e102.0] for the low-density samples
and 17.0 [range, 0.0e60.0] for the high-
density samples; P¼.300).
Comment
We conducted a thorough analysis of
nerve ﬁbers in the vestibular mucosa of
patients with PVD and healthy control
subjects by using 2 different neural
markers, PGP9.5 and NF2F11. We
showed that the density of IENFs in theogy DECEMBER 2016vestibular mucosa was greater in PVD
than in control subjects. Recently, we
demonstrated the existence of the VALT4
and showed evidence of immune acti-
vation in PVD by identifying germinal
centers and higher densities of B cells in
PVD than in control subjects. We now
show that the epithelial neuro-
proliferation is associated with VALTand
takes place around the areas with B-cell
inﬁltration. Our results suggest that im-
mune activation explains the neuro-
proliferation and may contribute to the
altered pain sensation in PVD.
Germinal centers emerge in the mu-
cosa as a sign of immune activation.
Although germinal centers mostly
consist of B cells, T cells are also present
in the follicular area and have important
functional roles as helper cells that
stimulate the immune responses.20
Density of T cells did not show effect
on neuroproliferation. This is in line
with our earlier study in which we, un-
like others,3,21 found no difference in
T-cell density between patients and
control subjects. Further studies are
needed to dissect the different T-cell
subgroups in relation to nerve ﬁbers and
development of germinal centers.
PGP9.5 is a well-established neuron-
speciﬁc marker that detects the thinnest
unmyelinated sensory C ﬁbers, which
are <1 mm in thickness.22 PGP9.5 is the
gold standard biomarker for IENFs.
However, it is a pan-neuronal marker
and, besides the small ﬁbers, also stains
subepithelial nerve bundles. Previous
studies on PVD have shown an overall
abundance of neural tissue in the
vestibular mucosa of patients with PVD
with no quantiﬁcation of the IENF
density.3,11,23 Thus, by calculation of the
linear density of IENFs, the validated
method of evaluating IENFs, we were
able to demonstrate an actual increase in
the IENFs in PVD. Furthermore, we
found that only the expressions of IENFs
differed between PVD and control
samples and between inﬂammatory and
noninﬂammatory areas; the overall
density of neural tissue in the stroma
(detected by PGP9.5 and NF2F11) was
comparable. This ﬁnding disagreed with
a previous study that showed neural
hyperplasia by PGP9.5 in PVD
FIGURE 3
Nerve growth factor positive immune cells in the vestibular mucosa
Immunostaining for nerve growth factorepositive immune cells (red) in A, provoked vestibulodynia
and B, control. Histologic sections were counterstained with hematoxylin and photomicrographed
with a 20 objective.
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with studies that used S-100 stain-
ing.3,23,24 However, the S-100 antigen is
not speciﬁc to neural tissue but may also
stain structures of dendritic cells.25
Dendritic cells are numerous in the
stroma and epithelium of vestibular
mucosa, which may cause misinterpre-
tation.4 We did not ﬁnd any difference in
the IENF density or in the density of
subepithelial neural tissue between pri-
mary and secondary PVD, contrary to
previous reports that have suggested
predominance of the overall neural tis-
sue in primary PVD.3,24
NF2F11 detects neuronal axons by
labeling the neuroﬁlaments of the cyto-
skeleton. Neuroﬁlament proteins are
expressed exclusively in neurons and are
essential for radial growth, axonal caliber
maintenance, and myelination of the
axons.26 In mature neurons, the neuro-
ﬁlaments are composed of 3 subunits
with different molecular weights. Phos-
phorylated forms of the subunits are
expressed by axons; the non-
phosphorylated forms represent somal
and dendritic proteins.27 Our study is
the ﬁrst to show NF2F11 expression
in the vestibular mucosal tissue. We used
the monoclonal 2F11 antibody, which
detects the light molecular weight
phosphorylated form of the subunit (the
NFL subunit, 70 kDa), that is known to
be crucial in the myelination process of
the axons.26 Thus, it is possible that thesenerve ﬁbers that are detected by the
NF2F11 antibody might be myelinated
A-delta ﬁbers that signal a faster mode of
sharp pain. It is important to note that
no NF2F11-positive epithelial nerve ﬁ-
bers were found in the control samples.
The unmyelinated C-ﬁbers and thinly
myelinated A-delta ﬁbers together
constitute the small caliber nerve ﬁbers.
These ﬁbers transmit cold, warm, and
mechanical nociceptive stimuli.28 Many
neuropathic pain states (such as diabetic
neuropathy, drug-induced neuropathies,
and the burning mouth syndrome) are
characterized by decreased density of
these small nerve ﬁbers.29,30 Decreased
density of these IENFs in a skin biopsy is
the hallmark of the diagnosis of small
ﬁber neuropathies.31 Our current
ﬁnding of a high density of intra-
epithelial small ﬁbers in PVD suggests
that PVD is not a small ﬁber neuropathy.
To our knowledge, the only 2 other ex-
amples with increased pain sensitivity
and increased density of IENFs that have
been documented in the literature are
rectal hypersensitivity disorder and dry
eye disorder.32,33 Little is known about
the distribution of nerve ﬁbers in the
genital mucosal tissue of healthy women.
We, like others,2,34 demonstrated
the histopathologic characteristic of
increased lymphocytic inﬂammation,
especially around the vestibular glands in
PVD. We also demonstrated nerve ﬁbers
in the glandular epithelium by bothDECEMBER 2016 AmeriPGP9.5 and NF2F11 stainings. In
agreement with our ﬁnding of IENFs,
the density of nerve ﬁbers was higher in
the glandular epithelium of glands with
surrounding B-cell inﬁltrates than in
area without B cells. These are the ﬁrst
data on the nerve supply of the vestibular
glands. The glandular innervation may
also be a relevant factor in the sensitized
pain perception in PVD.
Recent research has revealed that
neuropathic pain because of different
diseases indicates different somatosen-
sory proﬁles.35 By quantitative sensory
testing, it is possible to distinguish be-
tween disorders with irritable noci-
ceptors that show positive (ie, sensory
gain) sensory signs and disorders with
nonirritable nociceptors that show
negative (ie, sensory loss) sensory signs.36
Many studies that have compared pa-
tients with PVD with pain-free control
subjects have shown lower tactile, pain,
and thermal thresholds and higher
suprathreshold magnitude estimations
for heat in the vulvar vestibule in
PVD.37,38 Only ﬁndings that have sug-
gested sensory gain have been reported.39
This might well be a result of increased
density of irritable nociceptors.
Increased density and sensitivity of
IENFs in PVD might be due to the up-
regulation of NGF because of a previ-
ous inﬂammatory process and immune
activation. In addition to our ﬁnding of
epithelial neuroproliferation and its as-
sociation with immune activation,
others have shown increased density of
the TRPV1 in PVD.12 NGF induces
nerve sprouting and contributes to the
generation of inﬂammatory hypersensi-
tivity and allodynia.40-42 Inﬂammatory
and immune cells are major sources of
NGF.19 In a recent study on experi-
mental chronic prostatitis in mice,
Schwartz et al43 showed elevated levels of
NGF in the prostate tissue and up-
regulation of TRPV1 in the dorsal root
ganglion neurons. We found an
increased number of NGF-positive im-
mune cells in the mucosal areas with
B-cell inﬁltration and IENFs in PVD but
could not show any difference in the
number of NGF-positive cells between
PVD and control samples. However,
IENFs were present in only some of thecan Journal of Obstetrics& Gynecology 768.e6
Original Research GYNECOLOGY ajog.orgcontrol samples, which may have caused
bias. Furthermore, without analyzing the
actual tissue level differences of NGF, no
conclusions about the role of NGF in
PVD pain generation can be drawn. It
may be a question of the amount of NGF
produced and not the number of cells
producing it. Also, NGFmight have been
up-regulated already in an earlier phase
of the disease and could no longer be
veriﬁed in these samples that represent a
late phase of the condition. NGF recently
has been linked to many other syn-
dromes that indicate chronic and
neuropathic pain; research that targets
blocking NGF is ongoing.19 Encouraging
results on the novel protein kinase in-
hibitor dilmapimod in reducing cyto-
kine production of the immune cells
have been reported.44 Thus, as 1 poten-
tial drug candidate, the protein kinase
inhibitor could inhibit neurogenic
inﬂammation in PVD.
Our study is the ﬁrst to report the
linear density of IENFs in PVD and is the
ﬁrst to show the expressions of NF2F11-
positive, possibly A-delta ﬁbers, and
innervation of the vestibular glands. A
further strength is the higher number of
proven cases and control cases than in
most previous tissue studies on
PVD.3,11,45 The 3-year age difference
between cases and control cases, all being
premenopausal, is unlikely to play a role.
In line with many previous studies on
vestibular tissue, our challenge was the
size difference between the PVD and
control samples. To minimize the bias
and to secure appropriate comparison,
the control biopsy samples were taken
exactly from the 5 o’clock position of the
posterior vestibule. This is the most
representative area of pain in PVD that
has been indicated by studies on vulvar
painmapping and studies on the effect of
surgical treatment of PVD.46,47 In addi-
tion, the depth of all analyses was limited
to 1.25 mm according to the depth of
control biopsy samples to minimize the
sample size bias. However, the size dif-
ference may have biased the evaluation
of the focally distributed NF2F11 ﬁbers.
The lack of gland tissue in the control
samples probably was due to the small
size of the biopsy samples. Most impor-
tantly, however, the linear density768.e7 American Journal of Obstetrics& Gynecolevaluation of the C-ﬁbers (numbers per
length unit, millimeters) was not
compromised because of the sample size
difference. Dual staining to reveal the
TRPV1 channels in the C-ﬁbers would
have been useful. The detection of
myelin structures in the NF2F11-
positive ﬁbers could have conﬁrmed
the A-delta nature of the ﬁbers.
We provide new information to the
question of the key mechanisms of
allodynia in PVD. NGF may be up-
regulated because of the activation of
VALT and in turn induces sprouting and
sensitization of the nociceptive nerve ﬁ-
bers, which suggests a key role to the
interplay between immune and neural
systems. Future research that will focus
on mechanisms in PVD might lead ul-
timately to the development of new
therapeutic interventions. n
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